Faculty Bibliography

BACKGROUND CONTEXT: Several studies have suggested that Hounsfield units (HU) in the spine are associated with increased complications for adult spinal deformity (ASD) patients. PURPOSE: The aim of this study is to assess whether there exists a threshold for HU that is associated with increased blood loss following ASD surgery. We hypothesize that HU below thresholds on spinal CT are predictive of increased blood loss during surgery and implant complications within 90 days after surgery for ASD. STUDY DESIGN/SETTING: Retrospective analysis. PATIENT SAMPLE: ASD patients who had HU measured in the spine were identified from a multicenter database. OUTCOME MEASURES: High Intraoperative blood loss and implant complications within 90 days of surgery.
METHOD(S): HU at L1, upper instrumented vertebrae (UIV) and total averages were assessed. Threshold linear regression with Bayesian information criteria was utilized to identify optimal cut-offs for predicting high blood loss (>2100mL, top 25% by volume) or any implant complications within 90 days. Implant complications included loosening, breakage and dislocation of rods or screws. Multivariable logistic regression was utilized controlling for age, gender, comorbidity, osteotomy and levels fused.
RESULT(S): Of 527 patients included, the mean age was 61+/-14. Mean L1 HU was 154.59+/-87, UIV HU was 175.1+/-304, and total average HU was 165+/-168. There were 59 patients with high blood loss (mean 5,026+/-233ml) and 467 with low blood loss (1,331+/-39.5ml). Threshold regression analysis identified that a cut-off of =140.33 was optimal for predicting high blood loss and =99.75 total average HU was optimal for predicting implant complications within 90 days of surgery. On multivariable analysis, L1 HU less than 140 was associated with 1.57x higher odds of high blood loss (P=0.032). Total average HU less than 100 was associated with a 3.6x higher odds of having an implant related failure within 90 days of surgery (P=0.035).
CONCLUSION(S): In this prospective multi-center study, Those with L1 HU=140 had a 1.52x higher odds of high blood loss. Patients with an average HUof =100 have 3.6x higher odds of implant related complication within 90 days of surgery. FDA DEVICE/DRUG STATUS: This abstract does not discuss or include any applicable devices or drugs.
Copyright

BACKGROUND CONTEXT: As adult spinal deformity (ASD) prevalence increases in our ever-aging population there is a concomitant increase in poor bone quality. ASD surgery is expensive and carries a high complication profile. It is important to optimize modifiable preoperative risk factors, such as osteopenia or osteoporosis. Additional diagnostic modalities such as a DEXA can add cost, delay diagnosis, and can be an additional insurance hurdle. Some studies suggest HU's can be utilized as a proxy for frailty, but it is unclear if this is useful in risk stratification. PURPOSE: Our goal was to evaluate the relationship between bone health as measured by HU's and PJK and identify a HU threshold in which PJK risk is increased. We hypothesize that HU will correlate with occurrence of PJK after ASD surgery. STUDY DESIGN/SETTING: Retrospective review of a prospective, multicenter ASD database. PATIENT SAMPLE: Of 1,330 pts eligible, 997 (74.9%) had complete 2Y follow-up. Of these, 605 meet inclusion criteria with 110 (18.18%) patients having a PJK. OUTCOME MEASURES: Development of PJK within 2 years of surgery.
METHOD(S): Operative ASD patients (scoliosis >20, SVA>5cm, PT>25, or TK>60) with available baseline (BL) and 2-year (2Y) radiographic and HRQL data were included if they had a preop CT. HU were measured from axial views within the cancellous body (x3) at both L1 and UIV with the mean value calculated for each. Threshold linear regression with Bayesian information criteria was utilized to identify optimal cut-offs of risk factors for PJK. Multivariable analysis (MVA) controlled for PJK prophylaxis and surgeon. Additionally, risk factors identified were controlled against each other.
RESULT(S): Threshold regression identified that cut-offs of <125 HU for UIV, >63 years for age, >0.31 for ASD-FI, and >47degree for preoperative T4-12 thoracic kyphosis, and <10 levels fused were predictive of PJK on bivariate analysis (P<0.05 for all). On MVA, age > 63 years old (OR 4.7; P = 0.003), female gender (OR 3.33; P=0.035), HU at UIV vertebrae <125 (2.83; P=0.008), ASD-FI >0.31 (OR 4.02; P=0.011), TK > 46degree (OR 3.75; P=0.003), and < 10 levels fused (OR 3.31; P=0.0310) were associated with increased odds of PJK.
CONCLUSION(S): Bone health as measured by HU appears to be an independent predictor of PJK after ASD surgery, specifically values <125 at the UIV. It also parallels frailty in prediction of PJK and can potentially be used as a proxy for frailty assessment. This can be easily measured and could help with risk stratification in the future. FDA DEVICE/DRUG STATUS: This abstract does not discuss or include any applicable devices or drugs.
Copyright

BACKGROUND CONTEXT: Prophylaxis usage has been established in literature as an important component of minimizing the risk of proximal junctional kyphosis (PJK) and proximal junctional failure (PJF) development. However, literature is scarce on the effects of prophylaxis in patients who have achieved adequate postoperative alignment and those who maintained poor alignment postoperatively. PURPOSE: To investigate how PJK prophylaxis impacts rates of PJK and PJF with and without ideal alignment and the associated cost/cost-effectiveness. STUDY DESIGN/SETTING: Retrospective cohort study of a prospective adult thoracolumbar deformity database. PATIENT SAMPLE: This study included 1,541 patients. OUTCOME MEASURES: Radiographic alignment, patient-reported outcome measures (ODI), cost per QALY.
METHOD(S): Operative adult spinal deformity patients (scoliosis >20degree, SVA>5cm, PT>25degree, or TK>60degree) with an UIV at L1 or below and available baseline (BL) and 2-year (2Y) radiographic and HRQL data were included. "Matched" and "unmatched" alignment refers to the age-adjusted alignment criteria. PJK prophylaxis was defined by usage of cement, hooks or tethers. PJF was defined as PJK with reoperation. Costs were calculated using the PearlDiver database, accounting for additional costs of prophylaxis when applicable, through estimates from Medicare pay scales for services within a 30-day window, including estimates regarding costs of postoperative complications, outpatient healthcare encounters, revisions and medical related readmissions. QALY was calculated using SF6D.
RESULT(S): A total of 738 ASD patients or below met inclusion criteria (59.9yrs+/-14.0, 79%F, BMI: 27.7 kg/m2 +/-6.0, CCI: 1.8 +/-1.7). Surgically, patients had a mean level fused of 11.1+/-4.4, LOS of 7.9 days+/-4.4, EBL of 1577 mL, operative time of 377 min, with 63% undergoing an osteotomy. Forty percent of patients had PJK prophylaxis. Controlling for age, CCI, BL osteoporosis, levels fused, usage of 3CO, UIV, BL SVA and BL PI-LL, patients who were matched postoperatively in PT, SVA, or PI-LL had lowered PJF rates (OR:.5, 95% CI:.28-.86, p=.01) with prophylaxis. Among those unmatched in either SVA, PILL, or PT by 6W, prophylaxis significantly reduced the rates of PJK and PJF as well (p <0.05). ANCOVA controlling for age, CCI, BL osteoporosis, levels fused, usage of 3CO, UIV, BL SVA and BL PI-LL shows patients with ideal age-adjusted alignment and prophylaxis resulted in a lower cost per QALY by 2Y ($399,948 vs $514,228, p <.001). Similarly, in unmatched patients, prophylaxis resulted in a substantially lower cost per QALY by 2Y ($466,409 vs 672, 024, p <.001), primarily due to decreased costs of reoperation and greater improvements in QALY among prophylaxis cohorts.
CONCLUSION(S): Despite additional surgical cost, optimization of radiographic realignment in conjunction with utilization of proximal junctional failure prophylactic techniques achieves ideal cost utility, predominately due to the minimization of mechanical failure related reoperations. Even among those not achieving optimal alignment, junctional prophylactic measures improved cost utility, emphasizing its critical role of minimization of junctional failures to achieve cost efficiency in adult spinal deformity surgery. FDA DEVICE/DRUG STATUS: This abstract does not discuss or include any applicable devices or drugs.
Copyright

BACKGROUND CONTEXT: Prior reports have focused on grading fusion status after adult spinal deformity (ASD) surgery; however, few focused on fusion status after 4-years postop. PURPOSE: To identify risk factors for nonunion in a prospective cohort of ASD patients with long-term follow-up (=4 years). STUDY DESIGN/SETTING: Prospective multicenter observational series. PATIENT SAMPLE: Database enrollment required age =18 years, scoliosis =20degree, sagittal vertical axis (SVA) =5cm, pelvic tilt =25degree, or thoracic kyphosis =60degree. OUTCOME MEASURES: Fusions were rated as bilaterally fused (A), unilaterally fused (B), partially fused (C), or not fused (D). Primary outcome was fusion (grade A or B) vs nonunion (grade C or D) at minimum 4-year follow-up. Secondary outcome measures included health-related quality of life (HRQL) (Oswestry Disability Index [ODI], Short Form-36 [SF-36] scores, Scoliosis Research Society-22 [SRS-22r] scores).
METHOD(S): Surgically treated ASD patients prospectively enrolled into a multicenter study (2008-2020) were assessed for fusion (grade A or B) vs nonunion (grade C or D). Inclusion required postop fusion grading at minimum 4-year follow-up. Demographics, frailty, comorbidities, alignment (baseline and initial correction), index surgery (total levels fused, iliac fixation, interbody fusion [IBF], use of bone morphogenetic protein [BMP] and/or demineralized bone matrix [

BACKGROUND CONTEXT: Previous literature has demonstrated the advantages of lateral single position surgery (L-SPS) in the perioperative period; however, 2-year postoperative outcomes of this novel technique have not yet been compared to circumferential anterior-posterior fusion (FLIP) at 2-years postoperatively. PURPOSE: Evaluate the feasibility and safety of L-SPS technique against the conventional FLIP. STUDY DESIGN/SETTING: Multi-center retrospective cohort study. PATIENT SAMPLE: Patients undergoing primary AP (ALIF or LLIF) fusions with bilateral percutaneous pedicle screw fixation between L2-S1 with minimum 2-year followup at three institutions. OUTCOME MEASURES: Outcome measures included levels fused, operative time, estimated blood loss and perioperative complications. Radiographic analysis included lumbar lordosis (LL), pelvic incidence (PI), pelvic tilt (PT), PI-LL mismatch and segmental lumbar lordosis.
METHOD(S): Patients were grouped as L-SPS if anterior and posterior portions of the procedure were performed in the lateral decubitus position, and FLIP if patients were repositioned from supine or lateral to prone position for the posterior portion of the procedure. Groups were compared in terms of demographics, intraoperative, perioperative and radiological outcomes, complications and reoperations up to 2 years follow-up. Measures were compared using independent samples or paired t-tests and chi-squared analyses with significance set at p<0.05.
RESULT(S): A total of 442 pts met inclusion, including 352 L-SPS and 90 FLIP pts. Significant differences were noted in age (62.4 vs. 56.9; p= < 0.001) and smoking status (7% vs. 16%; p=0.023) between the L-SPS and FLIP groups. No differences between L-SPS and FLIP were noted in gender (57.4% female vs 57.8% female, p=1.000), BMI (30.0kg/m2 vs 29.3kg/m2; p=0.318). No differences were noted in number of levels fused between L-SPS and FLIP (1.45vs 1.50; p=0.533), proportion including ALIF (38% vs 39%; p=0.809), or the proportion of surgeries including L5-S1 (38%vs 31%; p=0.222). Perioperative outcomes: L-SPS demonstrated significantly lower Op time (97.7min vs 297.0 min; p < 0.001), fluoro dose (36.5mGy vs 78.8mGy; p < 0.001), EBL (88.8mL vs 270.0mL; p < 0.001), and LOS (1.91 days vs. 3.61 days; p < 0.001) compared to FLIP. L-SPS also demonstrated significantly fewer post-op complications than FLIP (21.9% vs 34.4%; p=0.013), specifically regarding rates of ileus (0.0% vs 5.6%; p < 0.001). There was no difference in remaining surgical site, neurological, or medical complications between groups. Reoperation: N=no differences in reoperation were noted at 30-day (1.7%L-SPS vs 4.4%FLIP, p=0.125), 90-day (5.1%L-SPS vs 5.6%FLIP, p=0.795) or 2-year follow-up (9.7%L-SPS vs 12.2%FLIP; p=0.441). The most common reason for return to OR was Adjacent Segment Disease, (L-SPS 3.1% vs. FLIP 7.8%; p=0.067). Pseudarthrosis rates were similar between groups (0.0%L-SPS vs. 1.1%FLIP; p=0.204). Radiological Outcomes: no significant differences were noted in rates of radiological fusion (94.3% L-SPS vs 97.8%FLIP; p=0.266) or subsidence (6.9%L-SPS vs 12.2%FLIP; p=0.260). There were no differences noted between L-SPS and FLIP in change in LL from Baseline to 1-year (3.5 vs 2.8; p=0.466) and post-op to 1yr (-0.18 vs -0.51; p=0.777), or in PI-LL from Baseline to 1-year (-3.5 vs -3.2; p=0.835) and from post-op to 1-year (0.71 vs 0.71; 0.998).
CONCLUSION(S): L-SPS improves safety, improves operative efficiency and reduces complications in the perioperative period while maintaining similar efficacy of AP fusion at 2-year followup in treating degenerative lumbar spinal conditions. FDA DEVICE/DRUG STATUS: This abstract does not discuss or include any applicable devices or drugs.
Copyright

BACKGROUND CONTEXT: Sagittal alignment is integral to a patient's quality of life. Posterior spinal fusion (PSF) is currently the standard for correcting adolescent idiopathic scoliosis (AIS). Vertebral body tethering (VBT) is a fusionless growth modulating surgical technique used to treat AIS. It relies on the Hueter-Volkmann Law. Indications for this procedure include patients who have coronal curves up to 50degree, growth remaining, and no excessive thoracic kyphosis. VBT has been shown to have good coronal plane deformity correction. There have been fewer examinations of the sagittal effects of VBT. PURPOSE: To determine if VBT is a non-inferior treatment for correction of AIS with regard to sagittal alignment compared to PSF. STUDY DESIGN/SETTING: Multicenter retrospective cohort study. PATIENT SAMPLE: Patients with AIS who underwent correction surgeries with LIV in the lumbar spine from 2013 to 2021 with pre- and minimum two-year postoperative standing full spine plain films. OUTCOME MEASURES: Sagittal vertical axis (SVA), cervical SVA (cSVA), pelvic tilt (PT), thoracic kyphosis (TK), cervical lordosis (CL), L4-S1 lordosis (L4L), T1 pelvic angle (TPA) and pelvic incidence lumbar lordosis mismatch (PI-LL).
METHOD(S): Radiographic analyses was completed with independent samples t-test with significance set to p <0.05.
RESULT(S): A total of 99 patients were included, 49 VBT and 50 PSF. There were no differences in age or levels instrumented between groups. The VBT cohort Lenke class breakdown is 23% 1A, 13% 1C, 31% 3C. 18% 5C, and 15% 6C, while the PSF cohort consisted of 42% 1A, 6% 1B, 2% 2C, 2% 3B, 12% 3C, 2% 5B, 24% 5C, and 10% 6C. At Baseline, the VBT cohort had lower SVA (-0.7mm+/-3.7 vs 2.2mm+/-5.0, p=0.001), CL (-0.9degree+/-18.2 vs 11.6degree+/-12.8, p=0.001), L4-S1 Lordosis (20.7degree+/-16.0 vs 41.6degree+/-10.2, p=0.001), and higher cSVA (3.3mm+/-1.6 vs -0.95mm+/-3.1, p=0.001) than those who were fused. Postoperatively, VBT patients have an overall higher L4-S1 Lordosis (36.0degree+/-10.1vs 18.3degree+/-12.5, p=0.001), cSVA (3.4mm+/-1.4 vs -3.7mm+/-2.1, p=0.001), and lower CL (-4.3degree+/-18.4 vs 7.0degree+/-12.2, p=0.001). The PSF cohort had a larger change in cSVA (2.8mm+/-4.0 vs 0mm+/-1.6, p=0.001) from baseline to 2-year follow-up compared to VBT. No differences in the change of L4-S1 Lordosis (VBT 1.5degree+/-12.3 vs 4.1degree+/-10.9, p=0.3), TPA (VBT -1.6degree+/-6.8 vs -1.4degree+/-8.5, p=0.89), PT (VBT -0.5degree+/-7.8 vs -1.9degree+/-8.5, p=0.42), or PI-LL (0.2degree+/-12.0 vs -0.5degree+/-14.0, p=0.81) were observed.
CONCLUSION(S): VBT and PSF for AIS result in statistically similar changes in sagittal alignment parameters. The fact that we showed similar results comparing sagittal alignment in fusion and VBT groups indicates that VBT is non-inferior from a sagittal perspective. It is important to maintain sagittal alignment when correcting AIS. Future work can examine the long-term effect of VBT on sagittal alignment. FDA DEVICE/DRUG STATUS: This abstract does not discuss or include any applicable devices or drugs.
Copyright

BACKGROUND CONTEXT: While past research has shown racial disparities exist in the outcomes and utilization of spine surgery, those studies were often performed on nondisease-specific national databases, which may capture different patient populations and complication rates compared to prospective multicenter databases. PURPOSE: Purpose: 1) Assess racial disparities for enrollment in two prospective multicenter databases (ASD-

BACKGROUND CONTEXT: Tranexamic acid (TXA) is commonly used to lower blood loss in ASD surgery. Despite widespread use of TXA in ASD surgery, there is a lack of consensus regarding the optimal dosing intraoperatively. PURPOSE: This study aims to assess differences in blood loss and complications between high-dose, medium-dose, and low-dose TXA regimens. Complex ASD patients who receive high-dose TXA will have decreased blood loss compared to those who receive low-dose TXA. STUDY DESIGN/SETTING: Retrospective Review. PATIENT SAMPLE: A total of 265 ASD patients in a multi-center prospective study were retrospectively analyzed. OUTCOME MEASURES: Blood loss (ml), Major Blood Loss (>90th percentile ml), units transfused intraoperatively, units transfused perioperatively.
METHOD(S): Patients were separated into three cohorts by TXA regimen: 1) low-dose patients had =20mg/kg loading dose with =2mg/kg/hr maintenance dose 2) medium-dose patients had 20-50 mg/kg loading dose with 2-5 mg/kg/hr maintenance dose. 3) high-dose patients had =50mg/kg loading dose with =5mg/kg/hr maintenance dose. Major or minor blood loss was defined as above or below the 90th percentile of our cohort respectively. Multivariable analysis controlled for levels fused, BMI, platelets, Hgb, OR time, 3CO, and radiographic alignment.
RESULT(S): Fifty-four (20%) patients received low-dose regimen, 133 (50%) received medium-dose and 80 (30%) received high dose. Mean blood loss was 1,551+/-1,295 ml, intraoperative units RBCs 1.52+/-2, and perioperative units RBCs 2.3+/-2.3. Mean major blood loss was 4,566+/-1,516ml and minor blood loss 1,236+/-755ml. Compared to the low-dose group, patients in the high-dose group had 77.8% decreased odds of major blood loss (OR 0.222; P=0.007), decreased blood loss (Coef. -540.92ml; P=0.019), units transfused intraoperatively (Coef. -.739 units; P < 0.001), and units transfused perioperatively (Coef. -0.328 units; P=0.025). Compared to medium-dose group, the high-dose group had less units transfused intraoperatively (Coef. -.59 units; P < 0.001) and perioperatively (Coef. -.42 units; P < 0.001) with no difference in blood loss. There was no difference between the medium and low dose groups in blood loss or units transfused. There was no association between high-dose TXA regimen and increased rates of DVT, PE, or any medical complication before six weeks. No patients had a seizure.
CONCLUSION(S): In this multicenter prospectively collected database, ASD patients receiving high-dose intraoperative TXA have decreased odds of major blood loss, less RBC transfusions intraoperatively and 540ml less blood loss compared to low dose TXA, without additional risk of seizure or thromboembolic complications. FDA DEVICE/DRUG STATUS: This abstract does not discuss or include any applicable devices or drugs.
Copyright

BACKGROUND CONTEXT: Evidence on long-term maintenance of health status in adult spinal deformity (ASD) patients who improve above MCID threshold (MCID+) at 2 years following surgery is limited. PURPOSE: This study aims to: (1) evaluate whether patients who reached MCID+ status at two years postoperatively will maintain MCID+ status at 5 years, (2) identify risk factors associated with maintaining MCID+ status, and (3) Assess whether maintaining MCID+ status at 5 years is associated with satisfaction with surgery. STUDY DESIGN/SETTING: Retrospective review. PATIENT SAMPLE: Patients who underwent adult spinal deformity (ASD) surgery with minimum 5-year follow-up who achieved 2-year MCID in ODI were identified. OUTCOME MEASURES: Maintenance of MCID+ status at 5 years for Oswestry Diability Index (ODI).
METHOD(S): Patients who maintained MCID+ status at 5 years and those who did not formed the comparison groups. Multivariable logistic regression, controlling for age, complications after two years and two-year alignment, was used to identify risk factors associated with the inability to maintain MCID+ status. In a separate multivariable logistic regression, whether maintaining MCID+ status was associated with 5-year surgical satisfaction was assessed.
RESULT(S): Of 633 eligible patients, 339 had 5-year data. Of 133 with both 2- and 5-year data, 70 who achieved 2-year MCID in ODI were included. 30% (21) failed to maintain MCID+ status at 5 years. Preoperatively, 33% (23) were narcotic users, 47% (33) were frail and mean surgical invasiveness was 96.6+/-36.02. On multivariable logistic regression, preoperative variables were assessed: CCI > 3 (OR 5.75; p=0.026), ASA grade > 2 (OR 5.25; p=0.015), anemia (OR 19.74; p=0.009), and cancer (OR 6.46; p=0.015) were associated with increased odds of failure to maintain MCID+ status at 5-year follow-up. Patients who failed to maintain MCID+ status at 5 years had a higher odds of being unsatisfied with the surgery (OR 15.66; p=0.001). Frailty and surgical invasiveness had no significant impact on MCID+ status at 5 years.
CONCLUSION(S): Preoperative comorbid conditions significantly impact patient's long-term ability to maintain the positive gains in health-related quality of life measures from the surgery. Surgeons should continue to monitor and treat the chronic conditions to ensure maintenance of long-term recovery. FDA DEVICE/DRUG STATUS: This abstract does not discuss or include any applicable devices or drugs.
Copyright

BACKGROUND CONTEXT: Previous reports indicate postoperative complications have minimal impact on long-term outcomes after ASD surgery. Little data has evaluated the impact of complications on specific heath domains during postoperative period. PURPOSE: To evaluate the impact of specific complications on patient reported health domains compared to patients with no complications. STUDY DESIGN/SETTING: Prospective, multicenter, propensity score matched analysis. PATIENT SAMPLE: ASD patients enrolled into a prospective multi-center study. OUTCOME MEASURES: Oswestry Disability Index, Scoliosis Research Society-22r questionnaire (SRS-22r), Short Form-36v2 questionnaire (SF-36), postoperative complications.
METHOD(S): Surgically treated ASD patients enrolled into a multicenter study were assessed for postoperative complications requiring surgery including wound (WOUND), pseudoarthrosis (PSEUDO), neurologic (NEURO) and malalignment (MAL) and matched to patients with no complications (NOCOMP) using inverse probability weighting for demographic, radiographic and surgical variables. Health domains for SRS-22r, and SF-36 were evaluated at regular time intervals, domain scores normalized to the date of revision surgery, and compared to patients with no complications at minimum 2-year follow-up.
RESULT(S): A total of 566 of 1130 were analyzed, average 3.6 yrs (range: 1.9 to 9). WOUND (n=12) compared to NOCOMP (n=390) had worse SF-36 physical function(21.7 vs 27.4), social function(19.6 vs 28.9), general health (-7.3 vs 8.9) and vitality (-0.9 vs 26.6,p < 0.05). PSEUDO (n=64) was worse than NOCOMP for SRS-22r function, 1.4 vs 2.1, and SF-36 social function, (17.1 vs 28.9) (p < 0.05). NEURO (n=28) was worse than NOCOMP for SRS-22r (0.9 vs 2.1), SF-36 bodily pain (14.7 vs 35.7) and social function (13.4 vs 28.9) (p < 0.05). MAL (n=72) was worse than NOCOMP for SRS-22r pain, (2.7 vs 3.4), function (1.2 vs 2.1), self-image (3.0 vs 3.9), SF-36 bodily pain (27.6 vs 35.7), physical function (18.7 vs 27.4), and social function (11.6 vs 28.9) (p < 0.05).
CONCLUSION(S): Counter to previous reports, specific postoperative complications requiring surgery uniquely impact specific health domains, resulting in worse patient reported quality of life compared to ASD patients with no complications. Social function was negatively impacted for all complications, while wound complications negatively impacted patient perceived general health and vitality and patients with malalignment requiring surgery reported worse self-image. These data highlight new findings that postoperative complications have a negative impact on specific aspects of ASD quality of life that can undermine the potential benefits of ASD surgery. FDA DEVICE/DRUG STATUS: This abstract does not discuss or include any applicable devices or drugs.
Copyright